MX338724B - Composicion formadora de pelicula y uso de la misma para tratar herpes. - Google Patents

Composicion formadora de pelicula y uso de la misma para tratar herpes.

Info

Publication number
MX338724B
MX338724B MX2013015200A MX2013015200A MX338724B MX 338724 B MX338724 B MX 338724B MX 2013015200 A MX2013015200 A MX 2013015200A MX 2013015200 A MX2013015200 A MX 2013015200A MX 338724 B MX338724 B MX 338724B
Authority
MX
Mexico
Prior art keywords
film
forming composition
treating herpes
composition
relates
Prior art date
Application number
MX2013015200A
Other languages
English (en)
Other versions
MX2013015200A (es
Inventor
Nathalie Derain
Original Assignee
Urgo Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Urgo Lab filed Critical Urgo Lab
Publication of MX2013015200A publication Critical patent/MX2013015200A/es
Publication of MX338724B publication Critical patent/MX338724B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se relaciona con una composición tópica formadora de película que incluye, en un medio farmacéuticamente aceptable: de 5 a 30% en peso de etilcelulosa; de 0.1 a 10% de un agente auxiliar formador de película; de 0.1 a 20% en peso de uno o más triácidos, por lo menos uno de los cuales es ácido bórico; y de 60 a 95% en peso de un solvente orgánico, los porcentajes están expresados en peso relativo al peso total de la composición; la invención también se relaciona con el uso de tal composición en un método para tratar herpes, en particular, herpes labial.
MX2013015200A 2011-06-22 2012-06-21 Composicion formadora de pelicula y uso de la misma para tratar herpes. MX338724B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1155493A FR2976808B1 (fr) 2011-06-22 2011-06-22 Composition filmogene et son utilisation pour le traitement de l'herpes
PCT/FR2012/051417 WO2012175879A1 (fr) 2011-06-22 2012-06-21 Composition filmogène et son utilisation pour le traitement de l'herpès

Publications (2)

Publication Number Publication Date
MX2013015200A MX2013015200A (es) 2014-03-21
MX338724B true MX338724B (es) 2016-04-27

Family

ID=46456911

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013015200A MX338724B (es) 2011-06-22 2012-06-21 Composicion formadora de pelicula y uso de la misma para tratar herpes.

Country Status (17)

Country Link
US (1) US9226989B2 (es)
EP (1) EP2723385B1 (es)
JP (1) JP2014517060A (es)
KR (1) KR101898635B1 (es)
CN (1) CN103796682B (es)
AU (1) AU2012273819A1 (es)
BR (1) BR112013033145B1 (es)
CA (1) CA2839473C (es)
ES (1) ES2751100T3 (es)
FR (1) FR2976808B1 (es)
LT (1) LT2723385T (es)
MX (1) MX338724B (es)
PL (1) PL2723385T3 (es)
PT (1) PT2723385T (es)
RU (1) RU2578959C2 (es)
WO (1) WO2012175879A1 (es)
ZA (1) ZA201309630B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016164316A1 (en) 2015-04-06 2016-10-13 3M Innovative Properties Company Removable film forming gel compositions and methods for their application
CN107320766A (zh) * 2016-12-08 2017-11-07 沈阳圣劳伦斯医疗器械有限公司 一种用于皮肤浅表创面保护的组合物
WO2022133629A1 (zh) * 2020-12-21 2022-06-30 江苏奇力康皮肤药业有限公司 一种喷雾型液体创可贴及其制备方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4285934A (en) * 1979-07-13 1981-08-25 Tinnell James E Treatment for herpes virus
US4374126A (en) * 1981-02-23 1983-02-15 Warner-Lambert Company Film forming antimicrobial material
US4783335A (en) * 1985-11-18 1988-11-08 The Kendall Company Controlled topical application of bioactive reagent
EP0289900A1 (en) 1987-04-30 1988-11-09 Abbott Laboratories Topical antibacterial compositions
AU2252388A (en) * 1988-05-02 1989-11-29 Zila Pharmaceuticals Compositions and in situ methods for forming films on body tissue
US5081158A (en) 1988-05-02 1992-01-14 Zila Pharmaceuticals, Inc. Compositions and in situ methods for forming films on body tissue
JPH03275619A (ja) * 1990-03-23 1991-12-06 Nitsusui Seiyaku Kk 外用剤組成物
US5547662A (en) * 1993-08-27 1996-08-20 Becton, Dickinson And Company Preparation of a skin surface for a surgical procedure
CZ286758B6 (en) * 1994-03-21 2000-06-14 Thomsen John Brown Pharmaceutical preparation in the form of a gel for treating skin diseases
GB9408545D0 (en) 1994-04-29 1994-06-22 Zyma Sa Compositions
US5906814A (en) * 1995-12-07 1999-05-25 The Andrew Jergens Company Topical film-forming compositions
WO1997025018A1 (en) * 1996-01-11 1997-07-17 Launceston, Ltd. Scented nail polish
US5888494A (en) * 1996-03-12 1999-03-30 Adolor Corporation Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic and pruritic conditions therewith
US6231875B1 (en) * 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
AU762692C (en) * 1998-09-30 2007-01-11 Warner-Lambert Company Modified starch film compositions
FR2783832A1 (fr) * 1998-09-30 2000-03-31 Warner Lambert Co Compositions de film d'amidon modifie
DE60020716T2 (de) * 1999-07-22 2005-12-15 Warner-Lambert Co. Llc Filmbildende zusammensetzungen aus pullulan
MD1779G2 (ro) * 2001-06-29 2002-05-31 Молдо-франко-румынское совместное предприятие "ЕУРОФАРМ" с ограниченной ответственностью Compoziţie dermatologică peliculogenă cu juglonă (variante)
FR2832311B1 (fr) * 2001-11-21 2004-04-16 Besins Int Belgique Poudre filmogene, compositions la comprenant, leurs procedes de preparation et leurs utilisations
DK1545619T3 (da) * 2002-09-05 2008-05-26 Galderma Sa Oplösning til ungual påföring
FR2844197B1 (fr) * 2002-09-05 2006-06-23 Galderma Res & Dev Solution pour application ungueale et peri-ungeale
JO2492B1 (en) 2003-04-28 2009-10-05 شيرينج ايه جي A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients
US20050070501A1 (en) 2003-09-29 2005-03-31 New York Blood Center, Inc. Water dispersible film
GB0401113D0 (en) * 2004-01-19 2004-02-18 Glaxo Group Ltd Tooth whitening composition
US8586011B2 (en) * 2004-07-29 2013-11-19 Blonde Holdings Pty Ltd. Skin coating composition and uses thereof
CN102085164A (zh) * 2004-07-29 2011-06-08 布隆多控股有限公司 皮肤涂层组合物及其应用
US7691839B2 (en) * 2005-09-28 2010-04-06 Biovascular, Inc. Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation
AU2007260739A1 (en) * 2006-06-14 2007-12-21 Dr. Reddy's Laboratories Limited Topical compositions
JP2010511723A (ja) * 2006-12-04 2010-04-15 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー 局所医薬組成物
CN103933063A (zh) * 2007-11-30 2014-07-23 托尔特克制药有限责任公司 用于治疗阴道感染和致病性阴道生物被膜的组合物和方法
WO2009129470A2 (en) * 2008-04-18 2009-10-22 Nanobio Corporation Methods for treating herpes virus infections
US20100048598A1 (en) * 2008-08-21 2010-02-25 Sateesh Kandavilli Topical compositions comprising 5-alpha reductase inhibitors

Also Published As

Publication number Publication date
FR2976808B1 (fr) 2013-06-28
EP2723385B1 (fr) 2019-07-31
ES2751100T3 (es) 2020-03-30
JP2014517060A (ja) 2014-07-17
RU2014101705A (ru) 2015-07-27
BR112013033145A2 (pt) 2017-01-24
US20140130711A1 (en) 2014-05-15
FR2976808A1 (fr) 2012-12-28
US9226989B2 (en) 2016-01-05
WO2012175879A1 (fr) 2012-12-27
PT2723385T (pt) 2019-10-30
BR112013033145B1 (pt) 2021-01-12
RU2578959C2 (ru) 2016-03-27
KR101898635B1 (ko) 2018-09-13
CN103796682B (zh) 2016-06-29
EP2723385A1 (fr) 2014-04-30
CA2839473C (fr) 2019-09-24
MX2013015200A (es) 2014-03-21
AU2012273819A1 (en) 2014-01-16
CN103796682A (zh) 2014-05-14
ZA201309630B (en) 2015-04-29
KR20140045963A (ko) 2014-04-17
CA2839473A1 (fr) 2012-12-27
PL2723385T3 (pl) 2020-03-31
LT2723385T (lt) 2019-11-11

Similar Documents

Publication Publication Date Title
CA2875877C (en) Syk inhibitors
AR088195A1 (es) Composiciones farmaceuticas de n-metil-2-[3-(e)-2-piridin-2-il-vinil)-1h-indazol-6-ilsulfanil]-benzamida
MX2013004491A (es) Boronatos como inhibidores de arginasa.
WO2013142817A3 (en) Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo
MX2010010135A (es) Derivados de hidroximoil-tetrazol fungicidas.
GEP20146146B (en) Pyrrolopyrimidine compounds as inhibitors of cdk4/6
WO2014067986A8 (en) Galactoside inhibitor of galectin-3 and its use for treating pulmonary fibrosis
WO2012083122A8 (en) Inhibitors of influenza viruses replication
WO2008131860A3 (de) Pyridoncarboxamide, diese enthaltende nutzpflanzenschützende mittel und verfahren zu ihrer herstellung und deren verwendung
MA35749B1 (fr) Dérivés nucléosidiques 4'-azido, 3'-fluoro substitués en tant qu'inhibiteurs de la réplication de l'arn du vhc
MX2011008910A (es) Derivados de azol sustituidos, composicion farmaceutica que comprende los derivados, y uso de los derivados para tratar enfermeda de parkinson.
PH12014501967A1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
MX2013012151A (es) Metodo para inhibir microorganismos dañinos y composicion de formacion de barreras para los mismos.
UA97821C2 (en) Cyclized derivatives as eg-5 inhibitors
WO2011117377A3 (en) Compositions comprising brimonidine for the treatment of erythema
MX2013005508A (es) Compuestos de lipoilo y su uso para tratar lesion isquemica.
NZ602109A (en) Plant protection agent
WO2014102592A3 (en) Oxime/substituted quinoxaline-type piperidine compounds and uses thereof
NZ603828A (en) Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
WO2015042414A8 (en) Multicyclic compounds and methods of using same
WO2012090194A3 (en) Compositions and methods for treating a skin disorder
WO2013080140A3 (en) Sunscreen compositions containing a novel preservative system
MX338724B (es) Composicion formadora de pelicula y uso de la misma para tratar herpes.
WO2012134758A3 (en) Topical palmitoyl glutathione formulations
MX2015013240A (es) Método para proporcionar neuroprotección ocular.

Legal Events

Date Code Title Description
FG Grant or registration